Indefinite Delivery Contract SPE2DU25D9333

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to various Department of Defense (DoD) customers, including the Defense Health Agency, US Coast Guard, and US Naval Fleet.

The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is part of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple prime vendor contracts to support normal day-to-day operations, planned and unplanned contingencies, and war readiness for pharmaceutical requirements in the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS) regions. The solicitation for this program is expected to be issued in March 2024 and will be awarded on a lowest-price, technically acceptable basis.